Approval · Notice of Compliance 4219 · 1996
MEPRON: Notice of Compliance 4219
Issued April 4, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4219
- Date
- April 4, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form: oral suspension
- Therapeutic class
- Antiprotozoal
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MEPRON | 02217422 | Marketed |
Medicinal ingredients
- ATOVAQUONE 750 MG per 5ML